Source: Annual Congress 2007 - Difficult tuberculosis cases II
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Aydin, T. Cagatay, R. Yildiz, B. Erer, L. Pur, S. Kamali, M. Inanc, A. Gul, Z. Kilicaslan (Istanbul, Turkey). Follow up results for tuberculosis in patients who receive TNF antagonist treatment. Eur Respir J 2007; 30: Suppl. 51, 3842

Member's Comments

No comment yet.

Related content which might interest you: Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 The incidence of tuberculosis in patients taking anti TNF alpha therapy Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Follow up of newly detected patients with destructive lung tuberculosis who were failed at the end of 8-month chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005 One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014 Evaluation of follow up and treatment results of new tuberculosis cases Source: Eur Respir J 2003; 22: Suppl. 45, 522s Year: 2003 Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Follow up of newly detected patients with pulmonary tuberculosis who interrupted treatment and have not treated repeatedly Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Treatment and outcome of CRF patients with tuberculosis Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 The results of re-treatment patients with tuberculosis Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 IP-10 decreases during antituberculous treatment in children with active tuberculosis. Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020 Our approach about latent tuberculosis infection in patients who are given anti-TNF alpha therapy Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Short 12-month regimen with intravenouse linezolid for MDR-TB:  treatment outcomes and first follow up results. Source: International Congress 2018 – New developments in tuberculosis Year: 2018 Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011